You are here:
Gavi support for new and underused vaccines has contributed to the immunisation of an additional 370 million children.
Gavi plans to support the rollout of pneumococcal vaccines in over 40 countries by 2015.
Ten Gavi-eligible countries have added rotavirus vaccine to their immunisation programmes.
MenAfriVac vaccine could prevent 150,000 deaths by 2015 in Africa's "meningitis belt".
Gavi supports inactivated polio vaccine as part of routine immunisation programmes.
Gavi funds JE catch up campaigns. Countries self-finance the vaccine for routine immunisation.
Supporting the introduction of life-saving vaccines is not enough if the vaccines cannot reach the children who need them. Strong health systems are needed to deliver and scale-up new vaccines and to improve immunisation coverage and equity.
Over the course of a decade, the weighted average price of pentavalent vaccine (DTP-hepB-Hib) dropped by 43% from US$ 3.56 per dose in 2003 to US$ 2.04 per dose in 2013, with a lowest-ever price of US$ 1.19 from one supplier in 2013.
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2015
modal window here